Latest California Healthline Stories
Military Doctors In Crosshairs Of A Budget Battle
Details of the reductions have not yet been announced, but in 2017 Congress ordered mandated changes to make the military health system more efficient.
FDA Announces Sweeping Plan To Review Safety Of Surgical Staplers
The FDA said it might reclassify the widely used devices featured in a recent Kaiser Health News investigation.
Lawmakers United Against High Drug Prices Bare Partisan Teeth
Clear differences of opinion emerged between Democrats and Republicans during a House Ways and Means subcommittee hearing about how to make prescription drugs more affordable in the Medicare program.
Podcast: ‘What The Health?’ What’s Next For The FDA?
Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss the resignation of Food and Drug Administration Commissioner Scott Gottlieb, the latest on federal and state efforts to shore up the Affordable Care Act; and how public health officials plan to persuade parents who are reluctant to vaccinate their kids. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.
Patients Experiment With Prescription Drugs To Fight Aging
Doctors and patients say they’re compelled to use off-label meds as research goes unfunded.
A Mumps Quarantine In La. May Encroach On Rights Of Detained Immigrants
A recent outbreak at a Louisiana center triggered public health protections, but some immigration lawyers are crying foul.
Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
Cities and Counties Unlikely To Heed FDA Warning On Importing Foreign Drugs
The Food and Drug Administration claims CanaRX, a company used by more than 500 cities, counties and school districts to help their employees get cheaper drugs from overseas, has sent “unapproved” and “misbranded” drugs to U.S. consumers, jeopardizing their safety.
This Time When My Water Breaks, Take Me To A Hospital Without Surprise Bills
New research shows how an experience with surprise medical bills can guide patients’ future decision-making.
Big Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes
A Kaiser Health News database shows that $58 million flowed from drugmakers to patient groups running national ads.